Skip to content
healthcare.dev
Get a free key

Naproxen Sodium and Diphenhydramine HCl

NDC 62207-814, Naproxen Sodium and Diphenhydramine HCl, tablet, film coated, from Granules India Ltd.

Product NDC
62207-814
Status
Listed
Labeler
Granules India Ltd
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213663
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62207-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NAPROXEN SODIUM220 mg/1
  • DIPHENHYDRAMINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
62207-814-386220708143837500 TABLET, FILM COATED in 1 POUCH (62207-814-38)
62207-814-39622070814397500 TABLET, FILM COATED in 1 POUCH (62207-814-39)
62207-814-4762207081447500 TABLET, FILM COATED in 1 BOTTLE (62207-814-47)
62207-814-95622070814951 BOTTLE in 1 CARTON (62207-814-95) / 20 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62207-814 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62207-814 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62207-814. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.